A study of CAB CAR-T therapy in solid tumors.

Trial Profile

A study of CAB CAR-T therapy in solid tumors.

Phase of Trial: Phase I

Latest Information Update: 16 Jan 2017

At a glance

  • Drugs CAB CAR-T-Cell therapy (Primary)
  • Indications Solid tumours
  • Focus Adverse reactions
  • Most Recent Events

    • 16 Jan 2017 New trial record
    • 06 Jan 2017 According to a BioAtla media release, this trial is expected to initiate in 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top